映恩生物IPO,一场资本对赌下的造梦游戏

Ofweek光电信息网
11 Apr

本文系基于公开资料撰写,仅作为信息交流之用,不构成任何投资建议。打造“中国版第一三共”需要多长时间?朱忠远给出的答案是五年。靠着从第一三共挖角而来的多个重要研发人员,以及创始人朱忠远在医药创投圈的强大号召力,映恩生物仅用五年时间就搭建了涵盖12条ADC管线的在研产品矩阵,并与多家大药企达成了总金额超60亿美元BD交易。受益于此,公司的估值也从最初的1450万美元,飙升至IPO前的2.69亿美元,翻...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10